Talk:Efonidipine
Latest comment: 5 years ago by 108.16.253.48 in topic Pharmaceutical company marketing
 | This article is rated C-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | ||||||||||
| |||||||||||
 | Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Efonidipine.
|
Pharmaceutical company marketing edit
In the section "Efonidipine-The Best in Class", the author appears to rely on cherry-picking of primary sources to make claims that are not made in the sources themselves, and not verified by secondary medical sources. I think this is pharmaceutical company marketing. The rest of the article should get a thorough peer review as well. — Preceding unsigned comment added by 108.16.253.48 (talk) 14:12, 30 September 2018 (UTC)